Bankers Won't Push Valeant Pharma (VRX) into Default - OPI

Valeant Pharma (NYSE: VRX) is on watch following additional commentary from Orange Peel Investments on Thursday.

Key points of today's blog post include:

• Talk over the last week has been about VRX defaulting on its debt.
• Most people don't know the company has until the end of April before it defaults.
• Despite the public sentiment, we don't believe bankers want to push this company into default.

Shares of Valeant are indicated for a higher open.

You May Also Be Interested In

• SpaceX (SPCX) Shorts Receive Warning From Elon Musk
• This AI stock is "undervalued", Citi says
• Evercore says this stock could gain 45% if AI trade is back "in full force"